Patents
Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044)
08/1996
08/06/1996US5543389 Ointment containing antiproliferative drug bound to lipid carrier through linking and spacer groups, for rapid efficient drug delivery in treatment of skin disorders
08/06/1996US5543162 Polymeric capsules, method of making the same, and foodstuffs containing the same
08/06/1996US5543158 Copolymer of polyalkylene glycol and biodegradable polymer selected from polyanhydride, polyhydroxybutyric acid, polycaprolactones, polyorthoesters, polysiloxanes, polyglycolic acid or polylactic acid or copolymer
08/06/1996US5543157 Pharmaceutical inclusion compounds providing fast release of drug when wetted with water, e.g. body fluids
08/06/1996US5543156 Bioerodible devices and compositions for diffusional release of agents
08/06/1996US5543155 Diffusion-osmotic controlled drug-release pharmaceutical composition and process for preparing same
08/06/1996US5543154 Water insoluble coating having apertures through which surrounded core material comprising nifedipine mixed with polyacrylate polymer which hydrates into microparticle gel is released in situ
08/06/1996US5543153 Antacid
08/06/1996US5543152 Liposomes having membranes of sphingomyelin and cholesterol, acidic interior containing lipophilic drug
08/06/1996US5543151 Medical pressure-sensitive adhesive and medical bandage formed using the same
08/06/1996US5543150 Method of progesterone delivery and affect thereof
08/06/1996US5543148 Mixture of solvent, gelling agent and treatment agent
08/06/1996US5543135 Containing metallic oxide; biodegradable
08/06/1996US5543099 Process to manufacture micronized nifedipine granules for sustained release medicaments
08/06/1996US5542935 Apparatus for making therapeutic containing gas-filled liposomes
08/06/1996US5542920 Needle-less parenteral introduction device
08/06/1996CA2014451C Sustained-release oral drug dosage form
08/06/1996CA2009558C Therapeutic system for the transdermal or transmucous administration of active substances and the use thereof
08/06/1996CA1338509C Viscoelastic material for ophthalmic surgery
08/04/1996CA2168330A1 Procedure for encapsulating chlorpheniramine
08/02/1996CA2167620A1 Bolus for supplying biologically beneficial substances to ruminant animals
08/01/1996WO1996022793A1 Gene transfer for treating a connective tissue of a mammalian host
08/01/1996WO1996022790A1 Composition to ameliorate osteolysis and metastasis
08/01/1996WO1996022786A1 Sustained-release preparation and use
08/01/1996WO1996022778A1 Derivatives of succinamide and their use as metalloproteinase inhibitor
08/01/1996WO1996022774A2 Combinational drugs for treating migraine and other illnesses, comprising sesquiterpene lactones and b-complex vitamins
08/01/1996WO1996022768A1 Extended release clonidine formulation
08/01/1996WO1996022767A1 Pharmaceutical compositions in the form of slow release tablets based on high molecular weight polysaccharide granules
08/01/1996WO1996022766A1 Sulfated nonionic block copolymer surfactants as stabilizer coatings for nanoparticle compositions
08/01/1996WO1996022765A1 Stable lipid-comprising drug delivery complexes and methods for their production
08/01/1996WO1996022764A1 Liposomes containing a corticosteroid
08/01/1996WO1996022763A1 Liposome for destroying hiv and cells infected by said virus
08/01/1996WO1996022762A1 Aloe vera pharmaceutical compositions
08/01/1996WO1995031545A3 Diagnostics and treatments for cancers expressing tyrosine phosphorylated crkl protein
08/01/1996DE19503670A1 Sugar-free dragee suspension for coating pharmaceuticals and food
08/01/1996CA2211833A1 Gene transfer for treating a connective tissue of a mammalian host
08/01/1996CA2210482A1 Liposomes containing a corticosteroid
07/1996
07/31/1996EP0724004A1 Antioxidant-containing blowing agent
07/31/1996EP0723782A1 Use of a preparation comprising a plasminogen activator to improve wound healing
07/31/1996EP0723781A2 Transdermal formulation of xanomeline
07/31/1996EP0723777A1 Tablet containing enteric granules
07/31/1996EP0723455A1 Methods of inhibiting phagocytosis
07/31/1996EP0723440A1 Therapeutic delivery compositions and methods of use thereof
07/31/1996EP0723437A1 Multiple unit pharmaceutical preparation containing proton pump inhibitor
07/31/1996EP0723436A1 Multiple unit tableted dosage form i
07/31/1996EP0723435A1 Once-a-day metoprolol oral dosage form
07/31/1996EP0723434A1 New beads for controlled release and a pharmaceutical preparation containing the same
07/31/1996EP0723398A1 Superoxide dismutase and mimetics thereof
07/31/1996CN1128065A Material to be worn on the eyeball
07/31/1996CN1128028A N-morpholino-N-nitrosaminoacetonitril cyclodextrin inclusion complexes
07/31/1996CN1127992A Pharmaceutical compositions containing bactericidal permeability increasing protein and a surfactant
07/31/1996CN1127991A Method to inhibit restenosis
07/31/1996CN1127990A Encapsulated medicine
07/31/1996CN1127989A Improved nicotine lozenge and therapeutic method for smoking cessation
07/31/1996CN1127659A Natural medical health product "Compound snake powder"
07/31/1996CN1127657A Tonic hypoglycemic capsule and preparing process thereof
07/31/1996CN1127656A Kinetogenesis Chinese medicine for gastrointestinal tract
07/31/1996CN1127653A "Jiexuanling" medicine for treating scabies
07/31/1996CN1127652A Oral liquid for restoration of cancer
07/31/1996CN1127643A Woman climacteric function food and its producing method
07/31/1996CN1127640A Preparation for sobering up and preventing drunkenness and preparing method thereof
07/31/1996CN1127635A Pharmaceutical composition
07/31/1996CN1127634A Controlled release hormone microsphere injection and preparing method thereof
07/31/1996CN1127598A Chewing-gum contg. arteannuin
07/31/1996CN1032405C Process for preparing Herba Erigerontis injection
07/31/1996CN1032402C Granulated medicinal composition and prepn. method thereof
07/30/1996US5541231 Improving storage stability of the antidepressant, bupropion hydrochloride
07/30/1996US5541226 Topical compositions for re-epithelialization of persistent epithelial defects
07/30/1996US5541172 Controlled release systems and low dose androgens
07/30/1996US5541171 Orally administrable pharmaceutical composition
07/30/1996US5541170 Orally administrable pharmaceutical compositions
07/30/1996US5541155 Acids and acid salts and their use in delivery systems
07/30/1996US5540945 Pharmaceutical preparations for oral administration that are adapted to release the drug at appropriate sites in the intestines
07/30/1996US5540939 Encapsulating active materials
07/30/1996US5540938 Formulations and their use in the treatment of neurological diseases
07/30/1996US5540937 Process for preparing microspheres for the prolonged release of the LHRH hormone and its analogues, microspheres and formulations obtained
07/30/1996US5540936 Method of producing liposomes
07/30/1996US5540935 Reactive vesicle and functional substance-fixed vesicle
07/30/1996US5540934 Compositions for applying active substances to or through the skin
07/30/1996US5540931 Antiinflammatory agents using lanolin, oil, polysorbates and cyclosporins
07/30/1996US5540930 Nonagglomerating suspension
07/30/1996US5540928 Administering heparin in polymer matrix
07/30/1996US5540918 Use of certain anionic surfactants to enhance antimicrobial effectiveness of ophthalmic compositions
07/30/1996US5540912 Viscous suspensions of controlled-release drug particles
07/30/1996US5540909 Harmonic ultrasound imaging with microbubbles
07/30/1996US5540842 Method of producing an artificial kidney perfusion component for bicarbonate dialysis and the artificial kidney perfusion component
07/30/1996US5540227 Tonometer for applying fluorescein to eyes
07/30/1996US5540225 Method and apparatus for partial liquid ventilation or fluorocarbons
07/30/1996CA2072509C Cyclosporin emulsion compositions for oral administration
07/27/1996CA2141126A1 Combinational drug for treating migraine and other illnesses
07/25/1996WO1996022270A1 Biopolymers derived from hydrolyzable diacid fats
07/25/1996WO1996022110A2 Pharmaceutical products containing thermally-inhibited starches
07/25/1996WO1996022109A1 Utilization of ethoxylated fatty acid esters as self-emulsifiable compounds
07/25/1996WO1996022108A1 The use of activated protein c for preparing a pharmaceutical preparation
07/25/1996WO1996022107A1 Dried blood factor composition comprising trehalose
07/25/1996WO1996022103A1 Solid formulations for oral administration of cyclosporine a
07/25/1996WO1996022088A1 Anti-inflammatory eyedrops
07/25/1996WO1996022084A2 Polymer adhesive formulation containing sorbent particles
07/25/1996WO1996022083A1 POLYISOBUTYLENE ADHESIVES CONTAINING HIGH Tg TACKIFIER FOR TRANSDERMAL DEVICES
07/25/1996WO1996022082A1 Valaciclovir tablets containing colloidal silicon dioxide